论文部分内容阅读
目的为不宜手术切除的肝癌患者寻找一个有效的治疗方法。方法选择我院2001~2004年间不能手术切除的45例行射频治疗的肝癌病例资料进行回顾性分析。结果不能切除的肝癌进行射频治疗的45例患者中,体外经皮肝穿刺射频消融者32例,1、3年生存率为53%、31%;术中开腹直视下体内射频消融治疗者13例,1、3年生存率为31%、8%。结论对于不能手术切除的肝癌,体内、外射频消融治疗是一种有效的治疗手段。
The purpose is not suitable for surgical resection of liver cancer patients looking for an effective treatment. Methods Forty-five patients with unresectable HCC from 2001 to 2004 in our hospital were retrospectively analyzed. Results Among the 45 patients with unresectable HCC who underwent radiofrequency ablation, 32 patients underwent percutaneous transhepatic radiofrequency ablation in vitro. The 1-year and 3-year survival rates were 53% and 31%, respectively. The intraoperative radiofrequency ablation 13 cases, 1, 3-year survival rate was 31%, 8%. Conclusion For inoperable liver cancer, radiofrequency ablation is an effective treatment.